Differentiation of chronic obstructive pulmonary disease (COPD) including lung cancer from healthy control group by breath analysis using ion mobility spectrometry

M. Westhoff, P. Litterst, S. Maddula, J. I. Baumbach (Hemer, Saarbrücken, Germany)

Source: Annual Congress 2011 - Clinical application of exhaled biomarkers
Session: Clinical application of exhaled biomarkers
Session type: Oral Presentation
Number: 1699
Disease area: Airway diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Westhoff, P. Litterst, S. Maddula, J. I. Baumbach (Hemer, Saarbrücken, Germany). Differentiation of chronic obstructive pulmonary disease (COPD) including lung cancer from healthy control group by breath analysis using ion mobility spectrometry. Eur Respir J 2011; 38: Suppl. 55, 1699

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Proteomic analysis of plasma from COPD patients and smoking control subjects
Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology
Year: 2007



Next generation sequencing in lung adenocarcinoma of smokers with and without chronic obstructive pulmonary disease (COPD)
Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors
Year: 2017


Breath analysis in real time by mass spectrometry in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles
Year: 2013


The dynamic lung volume analysis in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 212s
Year: 2005

Can we use the evaluation of leukotriens in breath condensate for the diagnosis of chronic obstructive pulmonary disease (COPD)?
Source: Eur Respir J 2004; 24: Suppl. 48, 61s
Year: 2004

Modeling of oxygen uptake kinetics during exercise testing in patients with chronic obstructive pulmonary diseases (COPD)
Source: International Congress 2016 – Unmasking the mechanisms of symptoms and exercise limitation in disease
Year: 2016


Fat-free mass depletion and functional exercise capacity in COPD patients
Source: Annual Congress 2007 - Predicting factors of patients undergoing rehabilitation
Year: 2007


Early phenotypes of chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Different data in COPD
Year: 2015

Breath analysis by ion mobility spectrometry allows to discriminate COPD from lung cancer patients.
Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies
Year: 2018




Individual relationship between weather variables and lung function in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 385s
Year: 2005

Breath analysis by ion mobility spectrometry in COPD and lung cancer patients
Source: Annual Congress 2009 - Quality control in lung function and new developments
Year: 2009


Increased lung apoptosis and expression of ceramide in subjects with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009

The relationship between fibroblasts and airway structure in patients with asthma and chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 148s
Year: 2001

Impact of a single chronic obstructive pulmonary disease (COPD) exacerbation on lung function decline: Analysis of UPLIFT®
Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments
Year: 2012

The relationship between pulmonary function, health status, shuttle walk distance with sputum airway inflammation in moderate-to-severe chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 94s
Year: 2001

Phenotype of T cells in lung tissue from smokers with or without chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 53s
Year: 2005

Potential biomarkers in patients with chronic obstructive pulmonary disease (COPD)
Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Year: 2020


Comparison of survival rate following non-invasive ventilation in chronic obstructive pulmonary disease (COPD) and non-COPD patients
Source: Annual Congress 2010 - Noninvasive ventilation in the acute patient: outcome and pathophysiology
Year: 2010

Change in muscle mass in training patients with chronical obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 721s
Year: 2005

Pulmonary rehabilitation (PR) exercise tolerance improvement: Differences between interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions
Year: 2013